相关实验视频

Updated: May 24, 2025

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

在炎症性肺病中准CXCR2信号:由中性粒细胞驱动的炎症和新兴疗法

Md Sadique Hussain¹, Ahsas Goyal², Kavita Goyal³

¹Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India.

Naunyn-Schmiedeberg's archives of pharmacology

|March 6, 2025

概括

中性粒细胞由CXCR2信号引导,在炎症性肺病 (ILD) 中驱动肺炎和组织损伤. 用新疗法准CXCR2可能会改善患者对这些疾病的治疗结果.

科学领域:

肺部医学肺部医学
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

炎症性肺部疾病 (ILDs) 构成了全球严重的健康负担.
中性粒细胞是ILD肺炎和组织损伤的关键媒介.
中性粒细胞向炎症的肺组织的招募主要由化学因子受体CXCR2介导.

研究的目的:

调查CXCR2信号传递在中性粒细胞驱动的肺炎和ILDs组织损伤中的作用.
探索CXCR2及其配体 (IL-8/CXCL8,GRO-α/CXCL1) 的功能和结构特征.
评估针对ILDs的CXCR2向干预的治疗潜力.

主要方法:

在ILDs的背景下分析CXCR2在中性粒细胞迁移和激活中的作用.
研究CXCR2连体相互作用,包括IL-8 (CXCL8) 和GRO-α (CXCL1).
对用于ILD治疗的CXCR2抗剂进行的临床前和临床研究的审查.

主要成果:

在ILD中,CXCR2信号传递对中性粒细胞的招募和随后的组织损伤至关重要.
CXCR2对抗剂在调节中性粒细胞活性和减少疾病症状方面表现出潜在的潜力.
临床研究表明,CXCR2抑制药物的有效性和安全性非常有希望.

结论:

中性粒细胞和CXCR2在各种ILDs的发病过程中发挥着关键作用.
向CXCR2代表了一种有前途的治疗策略,用于改善ILD患者的临床结果.

关键词:

支气管切除症是一种支气管切除症.在 COVID-19 疫情中,CXCR2CXCR2CXCR2CXCR2CXCR2CXCR2C 慢性阻塞性肺病是一种慢性阻塞性肺病.一个ILD是ILDs.中性粒细胞中性粒细胞.

更多相关视频

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

Published on: December 15, 2014

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses

Published on: July 7, 2017

相关概念视频

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Cell-surface Signaling

Cell-surface Signaling

Hormones—or any molecule that binds to a receptor, known as a ligand—that are lipid-insoluble (water-soluble) are not able to diffuse across the cell membrane. In order to be able to affect a cell without entering it, these hormones bind to receptors on the cell membrane. When a first messenger, a hormone, binds to a receptor, a signal cascade is set off, causing second messengers, proteins inside the cell, to become activated, resulting in downstream effects.

Drugs Used in Lower Respiratory Disorders: Overview

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...